Pharmaceuticals

EW Group Signs with China's Largest Healthcare, Sinopharm

PETALING JAYA, Malaysia, June 15, 2023 /PRNewswire/ -- European Wellness Biomedical Group (EW Group), announced its partnership with HK VJM Ltd (representing Sinopharm Cloud Health Technology (Guandong) Co. and Sinopharm Traditional Chinese Medicine (Foshan) Co.) and NCL Solutions Sdn Bhd onApril...

2023-06-15 10:24 3196

MindRank Announces First-in-Human Phase 1 Study of MDR-001 in China

SHANGHAI and HANGZHOU, China, June 14, 2023 /PRNewswire/ -- MindRank, a clinical stage artificial intelligence (AI)-empowered drug discovery company, announced today that the first healthy volunteer dosed in the Phase 1 study of their oral small-molecule glucagon-like peptide 1 receptor agonist (...

2023-06-14 20:00 2510

Sirnaomics to Present Latest Developments on GalAhead™ Therapeutic Platform at Upcoming Industry Conferences

HONG KONG, GERMANTOWN, Md. and SUZHOU, China, June 14, 2023 /PRNewswire/ --  Sirnaomics Ltd.(the "Company"; stock code: 2257, together with its subsidiaries, the"Group" or "Sirnaomics"), a leading biopharmaceutical company in discovery and development of RNAi therapeutics, today announced that the...

2023-06-14 00:42 2419

The 20th CACLP & 3rd CISCE Closed with Record-breaking Numbers in Nanchang

NANCHANG, China, June 12, 2023 /PRNewswire/ -- From 28 to 30 May 2023, the 20th China Association of Clinical Laboratory Practice Expo (CACLP) and the 3rd China IVD Supply Chain Expo (CISCE), recognized as the world's leading in vitro diagnostics (IVD) exhibition, were successfully closed inNanch...

2023-06-12 18:45 2358

Taipei Entrepreneurs Hub Focuses on the Greater Health Industries, Taipei City Government Facilitates Global Talents Matchmaking

TAIPEI, June 12, 2023 /PRNewswire/ -- The Taipei City Government continues to promote the "Talent Exchange Program" in support of international entrepreneurs collaborating with companies inTaipei. Serving as the international startup community brand, Taipei Entrepreneurs Hub (TEH) is set to kick ...

2023-06-12 16:12 2042

Innovent Announces Phase 1 Clinical Data of IBI322 (CD47/PD-L1 Bispecific Antibody) in the Treatment of Anti-PD-(L)1-resistant Classic Hodgkin Lymphoma Patients at the EHA 2023 Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 12, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology an...

2023-06-12 08:00 5313

Treating COVID with Metformin Reduces Long COVID Rates

MINNEAPOLIS, June 9, 2023 /PRNewswire/ -- A new study published in The Lancet Infectious Diseasessupported by the Parsemus Foundation found a 41% reduction in Long COVID rates among people who used metformin at the time of COVID infection. The trial also saw a 42% reduction in emergency room visi...

2023-06-09 21:00 4789

Anti-Aging and Reproductive Medical Giants Gathered in Hong Kong Dragon's Medical Led Chinese Medical Development

HONG KONG, June 9, 2023 /PRNewswire/ -- Dragon's Medical successfully held its Advance Medical Technology Press Conference 2023 atW Hong Kong today, signing strategic partnership agreements with various medical groups fromMainland China, Hong Kong and Taiwan, deepening their long-term strategic pa...

2023-06-09 13:00 2147

China Approves the World's First Vaccine against XBB Descendent Lineages of SARS-CoV-2 for Emergency Use

CHENGDU, China, June 9, 2023 /PRNewswire/ -- On June 8th, 2023, Coviccine® Trivalent XBB.1.5-Recombinant COVID-19 Trivalent (XBB.1.5+BA.5+Delta) Protein Vaccine (Sf9 cell) developed by WestVac Biopharma/ West China Medical Center, Sichuan University was approved for EUA by relevant authorities in ...

2023-06-09 11:59 2994

Investor Open Day: Fosun Implements Business Streamlining and Resilience Building Strategy, Focusing on Core Businesses to Bring New Vitality

HONG KONG, June 9, 2023 /PRNewswire/ -- On 8 June 2023, the 2023 Fosun International Investor Open Day was held inShanghai. It was the first time that Fosun International had held a large-scale offline open day after the pandemic. More than 100 domestic and foreign investor representatives from B...

2023-06-09 11:16 4488

Telix Opens European Radiopharmaceutical Production Facility

* Telix has unveiled its new, state-of-art radiopharmaceutical facility in Brussels South as part of its first stage investment of €14.1 million ($A21.2 million)    * Located in Walloon's 'Radiopharma Valley' the facility will be a central hub for research and development for the region and f...

2023-06-08 20:00 2674

Qilu Pharmaceutical Announces Trials in Progress Posters on QL1706 in Phase III NSCLC Clinical Research at ASCO 2023

JINAN, China, June 8, 2023 /PRNewswire/ -- Recently, Qilu Pharmaceutical presented a Trials in Progress poster presentation on QL1706 (iparomlimab/tuvonralimab), an innovative bifunctional antibody for immunotherapy, in two Phase III non-small cell lung carcinoma (NSCLC) clinical studies at the ...

2023-06-08 15:35 2157

ACROBiosystems expands custom GMP-grade protein services to drive CGT development and commercialization

TOKYO, June 7, 2023 /PRNewswire/ -- Cell and gene therapy (CGT) is a cutting-edge therapy that combats cancer by bolstering the immune system through stem cell infusions or modified immune cells. However, manufacturing cell therapies isno easy feat. To support the commercialization of cell thera...

2023-06-07 16:05 2502

BetaLife wins Cytiva's first BioChallenge Competition in Southeast Asia

* BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes inSoutheast Asia. * Cytiva's BioChallenge aims to support the innovation of biotech startups. Singapore, June 7, 2023 /PRNewswire/ -- Cytiva recognizes the talent, resource and scal...

2023-06-07 12:00 2556

Colorcon, Inc. Invests in a New Film Coating Manufacturing Plant in Malaysia

Establishment of an eighth Colorcon film coating facility meets the expanding needs of the pharmaceutical and nutritional sectors inSoutheast Asia HARLEYSVILLE, Pa., June 6, 2023 /PRNewswire/ -- Colorcon, Inc. is proud to formally announce its investment in a new manufacturing plant in Johor Stat...

2023-06-06 20:00 3717

Telix to Present at Jefferies Healthcare Conference

MELBOURNE, Australia, June 6, 2023 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises that DrChristian Behrenbruch, Managing Director and Group CEO, will be presenting at the Jefferies Healthcare Conference being held inNew York from June 7 to June 9, 2023...

2023-06-06 08:40 2040

Transcenta Presents Updated Data of Osemitamab (TST001) in Combination with CAPOX as a First-Line Treatment of G/GEJ Cancer at 2023 ASCO Annual Meeting

SUZHOU, China, June 6, 2023 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta") (HKEX: 06628), a clinical stage biopharmaceutical company with fully-integrated capabilities in discovery, research, development and manufacturing of antibody-based therapeutics, has presented updated data of C...

2023-06-06 08:20 2401

Innovent and IASO Bio Updated Efficacy and Safety Clinical Data of Equecabtagene Autoleucel (BCMA CAR-T Cell Therapy) for Multiple Myeloma at the 2023 ASCO Annual Meeting

ROCKVILLE, Md. and SUZHOU, China, June 6, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, autoimmune, metabolic, ophthalmology and...

2023-06-06 08:00 3951

ASCO 2023: RemeGen Exhibits Promising Results of Disitamab Vedotin in Bladder Cancer

YANTAI, China, June 5, 2023 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a commercial-stage biotechnology company,  announced the latest clinical research results on disitamab vedotin (RC48) at this year's American Society of Cl...

2023-06-05 21:26 2640

RemeGen Demonstrates Profitability to Successfully Receive Approval from the Hong Kong Stock Exchange to Upgrade Stock Short Name

The "B" marker is removed from the Company's stock short name YANTAI, China, June 5, 2023 /PRNewswire/ -- RemeGen Co., Ltd.  ("RemeGen" or "the Company") (9995.HK, SHA: 688331), a fully-integrated commercial-stage biotechnology company, successfully obtained approval fro...

2023-06-05 21:17 3421
1 ... 29303132333435 ... 181